Dr Bernd Graßl brings his stock corporation, capital markets and corporate litigation expertise to GSK Stockmann’s Corporate team

Commercial law firm GSK Stockmann continues the strategic expansion of its Corporate team by welcoming Bernd Graßl as a partner at its Munich office with effect from 1 August 2025.

The new addition highlights the firm’s leading position in European commercial law and will enhance its range of advisory expertise for listed companies and international cases, as well as in corporate litigation.

Dr Bernd Graßl, formerly a partner at GLNS, has extensive expertise in stock corporation and capital markets law, public M&A and corporate law as well as in stock corporation and capital markets disputes and corporate litigation. His many years of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s growing Corporate team.

As a trusted expert in his field, Bernd Graßl will help to further strengthen the firm’s 360-degree advisory approach. This means that clients will benefit from even more comprehensive, customised solutions both in Germany and at GSK Stockmann’s international offices in Luxembourg and London. Bernd Graßl will bring fresh dynamism to the team, particularly when it comes to supporting capital market companies and advising on complex corporate law issues and the particularities of legal disputes involving listed companies.

“With Bernd Graßl on board, we are ideally positioned to advise and represent clients in the currently recovering stock market environment. His broad expertise and experience are a valuable addition to our Corporate team, both throughout Germany and internationally,” says Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division, commenting on the arrival of the new partner. “His proven track record in stock corporation and capital markets law, as well as in IPOs for tech companies, makes him a real asset for our clients and our team. The firm will also benefit greatly from his experience in corporate litigation.”

“Bernd Graßl’s expertise will enable us to provide our clients with even more comprehensive and strategic support in complex corporate law disputes,” adds Dr Justus Jansen, Managing Partner at GSK Stockmann. “His expertise complements our existing knowledge perfectly and will help us to continue to strengthen our position in the area of corporate litigation. This will allow us to offer our clients an even broader spectrum of high-quality advice – both here in Germany and internationally.”

Bernd Graßl is looking forward to his new role: “GSK Stockmann stands for legal advice of the highest quality, entrepreneurial foresight and a strong international network. I am looking forward to working with a highly motivated team to develop innovative, bespoke solutions for our clients, as well as expanding the firm’s range of services throughout Europe.”

GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective.

More about us: www.gsk.de